Clinical Trials Directory

Trials / Completed

CompletedNCT05132309

Intestinal Microbiota Composition in Patients With Chronic Pancreatitis and Pancreatic Exocrine Insufficiency

Study of Influence of Chronic Pancreatitis Severity Degree With Possible Complication of Pancreatic External Secretory Insufficiency on Intestinal Microbiota Composition Patterns

Status
Completed
Phase
Study type
Observational
Enrollment
96 (actual)
Sponsor
Federal Research and Clinical Center of Physical-Chemical Medicine · Academic / Other
Sex
All
Age
23 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Assessment of qualitative and quantitative composition of the intestinal microbiota in patients with CP; in patients with CP and PEI complication of mild to severe degree; patients with CP and PEI who underwent surgical intervention on the pancreas. Intergroup comparison of the microbial compositional characteristics and their analysis. Correction of enzyme replacement therapy in selected groups of patients with regard to the identified microbial characteristics. Assessment of the intestinal microbiota composition in dynamics after 6 (+1) months on the background of allocated therapy

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTenzyme replacement therapyCorrection of the previously prescribed dose of enzyme replacement therapy (ERT)/first time selection of ERT according to the severity of pancreatic exocrine insufficiency

Timeline

Start date
2020-11-01
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2021-11-24
Last updated
2021-11-24

Locations

2 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT05132309. Inclusion in this directory is not an endorsement.